The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Gut Bacteria-Based Supplements Can Cut Cravings for High Calorie Foods
People often plagued with cravings for their favorite guilty-pleasure foods might be in luck. New research has shown that consuming milkshakes with a supplement called inulin-propionate ester could mitigate cravings for chocolate, pizza, and other high-calorie foods.
Diet and Gut Microbiome Influences Multiple Sclerosis Disease Activity
Researchers used pre-clinical models of MS, as well as samples from patients with MS, in order to demonstrate that diet and gut flora may influence the activity of astrocytes, the cells that control inflammation and neurodegeneration in the brain.
Access to Hepatitis C Drugs Lacking for Native Populations
June 16th 2016Hepatitis C affects a disproportionate number of American Indian and Alaskan Native people, more than any other racial or ethnic group in the country, and treatment efforts are being hampered by limited government funding, according to a recent journal article.
Crohn's and Ulcerative Colitis can be Treated with Infliximab
The Remicade biosimilar inflectra (infliximab) appeared safe and effective for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC) across 38 weeks, according to a presentation at Digestive Disease Week 2016.
First Study to Analyze Dual Hormone Bionic Pancreas for Type 1 Diabetes at Home
June 11th 2016Patients with type 1 diabetes can safely lower their blood glucose levels and hypoglycemia in a home setting with the dual hormone (glucagon and insulin) bionic pancreas, a new study revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.
High Doses of Imodium Cause Serious Heart Problems, FDA Warns
Over-the-counter diarrhea drug loperamide (Imodium/Johnson & Johnson Consumer Inc.) has recently been in the news because opioid abusers have been using it to self-treat symptoms of opioid withdrawal. Others abuse it for its euphoric properties.
Could DAAs Stop an Epidemic of Hepatitis C among HIV-Positive Men?
The rate of transmission of hepatitis C virus (HCV) among HIV-positive men who have sex with men could be substantially reduced by the scaled up use of direct-acting antiviral (DAA) treatments along with behavioral interventions.
Metabolic Surgery is Now a Recommended Treatment for Obese Patients with Type 2 Diabetes
New consensus guidelines for the treatment of type 2 diabetes mellitus (T2DM) recommend, for the first time, that metabolic surgery be recommended or considered as an intervention for many obese patients.